Overall, we found that hyperglycemia is associated with poor health outcomes, and changes in cytokine levels, altered counts and functioning of dendritic cells, monocytes, and CD4+ T cells in patients with DM-TB. The gene discussed is CD4; the disease is Hyperglycemia.